APA (7th ed.) Citation

T, H., Y, N., E, O., S, K., J, Y., T, S., . . . T, Y. (2024). Bridging horizons beyond CIRCULATE-Japan: A new paradigm in molecular residual disease detection via whole genome sequencing-based circulating tumor DNA assay. International journal of clinical oncology, 29(5), 495. https://doi.org/10.1007/s10147-024-02493-4

Chicago Style (17th ed.) Citation

T, Hashimoto, Nakamura Y, Oki E, Kobayashi S, Yuda J, Shibuki T, Bando H, and Yoshino T. "Bridging Horizons Beyond CIRCULATE-Japan: A New Paradigm in Molecular Residual Disease Detection via Whole Genome Sequencing-based Circulating Tumor DNA Assay." International Journal of Clinical Oncology 29, no. 5 (2024): 495. https://doi.org/10.1007/s10147-024-02493-4.

MLA (9th ed.) Citation

T, Hashimoto, et al. "Bridging Horizons Beyond CIRCULATE-Japan: A New Paradigm in Molecular Residual Disease Detection via Whole Genome Sequencing-based Circulating Tumor DNA Assay." International Journal of Clinical Oncology, vol. 29, no. 5, 2024, p. 495, https://doi.org/10.1007/s10147-024-02493-4.